A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 10233217)

Published in Br J Dermatol on February 01, 1999

Authors

T J Dicker1, G M Kavanagh, R M Herd, T Ahmad, K M McLaren, U Chetty, J A Hunter

Author Affiliations

1: University Department of Dermatology, The Royal Infirmary of Edinburgh NHS Trust, UK.

Articles citing this

Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst (2010) 1.31

Sun protection and skin self-examination in melanoma survivors. Psychooncology (2009) 1.13

Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival. Br J Cancer (2002) 1.11

Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma. Eur J Nucl Med Mol Imaging (2007) 1.03

To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence? Int J Clin Pract (2014) 0.91

Correspondence between pigmented lesions identified by melanoma patients trained to perform partner-assisted skin self-examination and dermatological examination. Cancer Epidemiol Biomarkers Prev (2015) 0.84

Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review. Melanoma Res (2012) 0.84

Exploring patterns of recurrent melanoma in Northeast Scotland to inform the introduction a digital self-examination intervention. BMC Dermatol (2014) 0.80

Skin mapping with punch biopsies for defining margins in melanoma: when you don't know how far to go. Ann Surg Oncol (2008) 0.80

Long-term follow-up for melanoma patients: is there any evidence of a benefit? Surg Oncol Clin N Am (2015) 0.78

Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival. Ann Surg Oncol (2010) 0.78

Follow up for cutaneous malignant melanoma. Br J Dermatol (1999) 0.75

Articles by these authors

Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet (1990) 6.17

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93

Diagnosis of urinary tract infection in children: fresh urine microscopy or culture? Lancet (1991) 4.86

Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol (1989) 4.07

Cardiac outcome after peripheral vascular surgery. Comparison of general and regional anesthesia. Anesthesiology (1996) 3.65

The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology (1996) 2.74

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63

Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet (1992) 2.31

Malignant melanoma in Scotland 1979-1983. Lancet (1985) 2.30

Excision biopsy of malignant melanoma by general practitioners in south east Scotland 1982-91. BMJ (1992) 2.14

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Aliment Pharmacol Ther (2014) 2.11

Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ (1997) 2.08

Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol (1991) 1.98

Antiprostaglandin synthetase activity of nonsteroidal anti-inflammatory drugs and gastrointestinal micro-bleeding: a comparison of flurbiprofen with benoxaprofen. Ann Rheum Dis (1981) 1.97

Subcuticular skin closure following minor breast biopsy: Prolene is superior to polydioxanone (PDS) J R Coll Surg Edinb (1989) 1.97

Granulomatous lobular mastitis. J Clin Pathol (1987) 1.92

Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) (1986) 1.88

Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85

Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ (1989) 1.84

Benign breast disease and cancer. Br J Surg (1980) 1.80

Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res Treat (1993) 1.79

The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg (1985) 1.78

p53 mutations in breast cancer. Cancer Res (1992) 1.73

Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69

Post-irradiation morphoea. Br J Dermatol (1989) 1.69

Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69

Leg wound complications associated with coronary revascularization. J Thorac Cardiovasc Surg (1981) 1.67

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet (1990) 1.64

Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A (1985) 1.59

Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis. Histopathology (1990) 1.59

Xanthomatosis secondary to lymphoedema. Trans St Johns Hosp Dermatol Soc (1970) 1.59

Circular chloroplast DNA from Euglena gracilis. Proc Natl Acad Sci U S A (1971) 1.57

Goblet cell carcinoid of the appendix. Gut (1990) 1.57

Diffuse sclerosing papillary carcinoma of thyroid: a wolf in sheep's clothing. Clin Endocrinol (Oxf) (1989) 1.56

Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project. Lancet (1986) 1.56

NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther (2003) 1.54

Hyalinizing clear cell carcinoma of the oral cavity and of the parotid gland. ORL J Otorhinolaryngol Relat Spec (1999) 1.53

Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet (1983) 1.51

Stereotaxic localisation and aspiration cytology of impalpable breast lesions. Clin Radiol (1989) 1.51

Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51

Genetic and phenotypic variance and covariance components for feed intake, feed efficiency, and other postweaning traits in Angus cattle. J Anim Sci (2001) 1.49

Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49

Neurological abnormalities following open-heart surgery. J Thorac Cardiovasc Surg (1969) 1.48

Assessment of the acceptability of conservative management of fibroadenoma of the breast. Br J Surg (1996) 1.48

Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea]. J Lab Clin Med (1977) 1.48

Accuracy of prediction of genomic breeding values for residual feed intake and carcass and meat quality traits in Bos taurus, Bos indicus, and composite beef cattle. J Anim Sci (2013) 1.47

A randomised, controlled trial comparing a tissue adhesive (2-octylcyanoacrylate) with adhesive strips (Steristrips) for paediatric laceration repair. Emerg Med J (2002) 1.46

ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. Int J Cancer (2001) 1.46

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol (1993) 1.44

Comparative pathology of breast cancer in a randomised trial of screening. Br J Cancer (1991) 1.42

Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut (2003) 1.42

The treatment of plantar warts in the home. A critical appraisal of a new preparation. Practitioner (1971) 1.42

Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ (1988) 1.41

A human tumour model. Lancet (1986) 1.39

Fibrin-ring granulomas: a non-specific reaction to liver injury? Histopathology (1991) 1.39

Histological regression in primary cutaneous melanoma: recognition, prevalence and significance. Histopathology (1992) 1.39

Rupture of an otherwise normal aortic valve. Report of two cases and review of the literature. J Thorac Cardiovasc Surg (1968) 1.39

Perforating granuloma annulare. Int J Dermatol (1989) 1.38

The dermatology out-patient service: a study of out-patient referrals in a Scottish population. Br J Dermatol (1984) 1.38

Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet (1989) 1.37

Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol (1990) 1.36

Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol (1990) 1.36

Localization and excision of occult breast lesions. Br J Surg (1983) 1.34

Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet (1989) 1.34

Genome-wide association studies for feedlot and growth traits in cattle. J Anim Sci (2011) 1.33

Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30

Staples or sutures for mastectomy wounds? A randomised trial. J R Coll Surg Edinb (1983) 1.30

Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29

Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J (Clin Res Ed) (1985) 1.29

Seventeen-year experience with routine shunting in carotid artery surgery. World J Surg (1979) 1.28

Keratosis follicularis spinulosa decalvans: confirmation of linkage to Xp22.13-p22.2. J Med Genet (1998) 1.27

Recruitment to a prospective breast conservation trial: why are so few patients randomised? BMJ (1990) 1.24

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer (1990) 1.24

En bloc resection of colon cancer adherent to other organs. Am J Surg (1987) 1.23

White coat effects. BMJ (1996) 1.23

A neutral protease in rheumatoid synovial fluid capable of attacking the telopeptide regions of polymeric collagen fibrils. Biochim Biophys Acta (1975) 1.23

Comparison of general and local anaesthesia for biopsy of breast lumps. J R Coll Surg Edinb (1983) 1.21

Global gene expression profiling reveals genes expressed differentially in cattle with high and low residual feed intake. Anim Genet (2011) 1.20

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. Br J Cancer (1989) 1.20

Tranexamic acid (Cyklokapron)-induced fixed-drug eruption. Br J Dermatol (1993) 1.20

Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance. Br J Surg (1989) 1.20

NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut (2001) 1.19

Primary systemic therapy for operable breast cancer. Br J Cancer (1991) 1.19

Giant hogweed dermatitis. Scott Med J (1970) 1.19

Synthesis of macromolecules during induction of haemoglobin synthesis by erythropoietin. J Mol Biol (1969) 1.18

Cattle selected for lower residual feed intake have reduced daily methane production. J Anim Sci (2007) 1.18

The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc Natl Acad Sci U S A (1993) 1.17

Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer (1994) 1.16

Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology (2002) 1.16

Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut (2003) 1.15

Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer (2005) 1.14

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer (1992) 1.14

Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg (1994) 1.14

Ruptured abdominal aortic aneurysm. Surgical management. Arch Surg (1968) 1.11

Arteriosclerotic aneurysm of anomalous right subclavian artery. J Thorac Cardiovasc Surg (1970) 1.11